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Abstract
Background: Three antibacterial diterpenes: (5R,8R,9S,10R)-12-oxo-ent-3,13(16)-clerodien-15-
oic acid (1), 16-hydroxy-clerod-3,13(14)-diene-15,16-olide (2) and ent-12-oxolabda-8,13(16)-dien-
15-oic acid (3) were previously isolated form Premna schimperi and  P. oligotricha. Since
andrographolide and other structurally related diterpenes were shown to have antileishmanial
activity, the aim of the present study was to assess the in vitro effect of premna diterpenes against
Leishmania aethiopica; the causative agent of cutaneous leishmaniasis in Ethiopia.
Results:  The diterpenes showed potent concentration-dependant suppressive effect on the
viability of axenically cultured amastigotes of L. aethiopica. The clerodane diterpenes 1 and 2 were
most active (LD50 values 1.08 and 4.12 µg/ml respectively) followed by andrographolide and 3.
Compounds 1 and 2 appear to be over 20 and 10-times respectively more selective to leishmania
amastigotes than the permissive host cell line, THP-1 cells or the promastigotes stage of the
parasites.
Conclusion: The clerodane diterpenes (1, 2) which were more potent and selective than labdanes
(andrographolide and 3) are promising for further studies and/or development.
Background
Leishmaniasis is a vector-borne disease that is transmitted
by sandflies and caused by obligate intracellular protozoa
of the genus Leishmania. Current estimates indicate that
leishmaniasis affects people in 88 countries, with 350 mil-
lion at risk of contracting the disease and approximately 2
million new cases reported each year [1,2]. During the last
decade, the geographic region of leishmania as well as
incidence of infection significantly increased mainly due
to increased urban development and immunosuppressive
illnesses such as AIDs [1,3].
For many decades, the first choice of drug treatment for
leishmaniasis has been the pentavalent antimonials,
sodium stibogluconate (Pentostam) and meglumine anti-
monate [4]. Both drugs require parenteral administration
and apart from being expensive, shown to have variable
efficacies and produce some severe toxic side effects, the
developments of resistance by the parasites have been
reported [5–7]. In such cases, the use of other parenteral
and rather toxic alternative drugs such as amphotericin B
(AMB) and pentamidine are inevitable [4]. Although
recent developments in the search of new as well as
improved formulations of old drugs have been promising
[4,8], there is still an urgent need for new anti-leishmanial
drugs. As part of a systematic search programme for
antileishmanial agents of natural products-origin, the
present study assesses the potential of two clerodane (1,
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2) and a labdane (3; see Fig. 1) diterpenes from two Ethi-
opian  Premna sp.: P. schimperi Engl. and P. oligotricha
Baker(Verbenaceae). The diterpenes (1–3;  Fig. 1) were
more toxic to the axenically-cultured amastigotes of L.
aethiopica parasites than the insect vector-stage, promas-
tigotes, and the clerodane diterpenes (1, 2) appears to be
much more selective to axenic amastigotes than the per-
missive host cell line, THP-1 cells.
Results
Effects of test compounds on promastigotes viability
A variety of in vitro methods are now available to assess
the susceptibility of leishmania parasites to experimental
agents [[9] and references there in]. An initial attempt to
use the MTT (data not shown) and the alamar blue-based
cell viability measurements (Fig. 2) in the present study
was unsuccessful as the reductions of the dies by L. aethio-
apica promastigotes was very slow. Despite it being time
consuming, the gold standard in leishmania promastig-
otes susceptibility assays has been microscopic counting
and was used here effectively for routine assessment of
leishmanicidal activity.
As shown in Fig. 3a, premna diterpenes (1–3) as well as
andrographolide (4) displayed a weak activity against the
promastigotes stage of leishmania parasites. LD50 values
for compounds 1 and 4, which were by order of magni-
tude more potent than 2 and 3, were also shown in Table
1. For comparison purposes, the effect of the standard
antileishmanial agent, AMB was also assessed. The
observed effect for AMB (Fig. 3a and Table 1) was in close
agreement with those reported before [10] and appears to
be much stronger than those of the diterpenes (1–4)
studied.
Effects of test compounds on axenically cultured amastig-
otes viability
Typical morphological features of the axenically cultured
L. aethiopica parasites (two weeks old following initiation
of differentiation) exhibiting a rounded cellular appear-
ance together with loss or flagella and the expected clump
formation is shown in Fig. 4. Since this axenically cultured
parasites could readily reduce alamar blue (Fig. 2), the
bioassay of drugs against this stage of the parasite was rel-
atively easy. In comparison to the promastigotes, axeni-
cally cultured amastigotes of L. aethiopica were more
susceptible to diterpenes 1–4  than their promastigotes
counterpart (Fig. 3, Table 1). The order of potency was:
AMB >2 >1 >4 >3.
Figure 1
Structures of premna diterpenes (1–3) and other 
related antileishmanial compounds (4-6).
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Figure 2
Differential ability of promastigotes and axenically 
cultured amastigotes of L. aethiopica in reducing 
alamar blue. Alamar blue was added to promastigotes or 
axenically-cultured amastigotes and cells incubated for indi-
cated period of time. Fluorescence associated with alamar 
blue reduction was quantified as described in the methods 
section.
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Cytotoxicity of test compounds in THP-1 monocytes
The cytotoxicity of 1–3 and the positive controls,
andrographolide (4) and AMB is shown in Fig. 5 and
Table 1. The concentrations of test compounds that pro-
duced up to 100% lethality in axenic amastigotes did not
show toxicity to THP-1 cells. In agreement with previous
studies that showed cytotoxicity of 1–3 to mammalian
cells, in particular cancer cells [11,12], the compounds
were found toxic to THP-1 cells but only at concentrations
higher than those found to be lethal to axenic leishmania
amastigotes (Fig. 5a). Assessment of the LD50  values
(Table 1) revealed that the clerodane diterpenes (1, 2)
were much more selective to axenic leishmania amastig-
otes than permissive monocyte/macrophage host cells,
THP-1 or promastigotes. The standard antileishmanial
drug, AMB, did also show some toxicity to THP-1 cells at
its higher concentrations (Fig. 5b).
Discussion
In traditional medicine, the leaves extracts of Premna
schimperi are used to treat external injuries and secondary
infection in wounds [13]. Previous systematic biological
and phytochemical studies on this plant have identified
the clerodane diterpene 1 as the antibacterial principle
[13]. Subsequent studies on a related species, P. oligot-
richa, resulted in the isolation of two antibacterial diterpe-
nes, a clerodane (2) and labdane (3) [13,14] together with
various other compounds [15–17]. Primarily due to
owing the presence of an α,β-unsaturated moiety, com-
pound 1–3 did also show cytotoxicity to various cancer
cell lines [11,12]. A related labdane diterpene, androgra-
pholide (4, see Fig. 1), is also shown to possess antiprolif-
erative effects in cancer cells [18] but its non-toxic
concentrations are known to possess various other biolog-
ical activities including antiinflammatory, antiviral and
antithrombotic [19] and cytoprotective effects from toxins
[20,21]. Recently, andrographolide (4) has also demon-
strated to have antileishmanial effects in the in vivo model
of leishmaniasis [22]. Another antileishmaial diterpenes
of close structural similarity with compounds 1–3 are lab-
dane 5 [23] and abietane, 6 (Fig. 1) and its derivatives
[24], which have been shown to induce leishmanial cell
death at concentrations below that cause toxicity in mam-
malian host cells. With the established antileishmanial
effects of structurally related diterpenes, the aim of the
present study was to assess the in vitro effect of com-
pounds  1–3  against promastigotes and axenically-cul-
tured amastigotes of leishmania parasites.
For various reasons including simplicity in in vitro culture
maintenance, routine screenings of antileishmanial
chemotherapeutic agents are often based on promastig-
otes susceptibility assays. The cellular, molecular and bio-
chemical characteristics of amastigotes, responsible for
the clinical manifestation of leishmaniasis in humans,
however differ from promastigotes [25]. Hence, the chem-
otherapeutic potential of drugs for leishmaniasis must
further be validated using the intracellular-amastigote
forms of the parasites. Since anti-amastigote assays using
ex vivo cultured macrophages or permissive cell lines has
various limitations [25], recent researches in many labora-
tories have focussed on the development of in vitro culture
conditions for maintenance and bioassays using
Figure 3
Effects of diterpenes (1–4) and AMB on L. aethiopica 
promastigotes (panel-A) and axenic amastigotes 
(panel-B) viability. Experiments were carried out as 
described in the methods section. Data points represent 
mean and SEM values obtained from three (panel-A) or 5 
(panel-B) replicates. Symbols indicate: * AMB, ■  1, ▲  2, ◆  3, 
and ●  4.
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axenically-cultured amastigotes. For some leishmania spe-
cies, including the L. aethiopica strain (MHOM/ET/72/
L100) used in the present study, temperature elevation
alone could result in differentiation of promastigotes to
amastigotes [26–28]. Lowering the pH to 5.5 together
with temperature elevation and 5% CO2-air mixture have
now been widely used not only to differentiate promastig-
otes to amastigotes but also for their long-term culture
[28,29]. Hence, this well established condition and
medium 199 [28] were used in the present study to obtain
and maintain L. aethiopica axenic amastigotes. The result-
ing axenic amastigotes of L. aethiopica could differentiate
back to promastigotes by centrifuging and re-suspending
them in promastigotes medium (RPMI 1640) followed by
incubation at 22°C. Phase contrast microscopic observa-
tions revealed the expected loss of flagella, cell rounding,
aggregate formation and the metabolic differences as evi-
denced by the ability of axenic amastigotes to readily
reduce alamar blue. While axenically cultured amastigotes
were able to reduce alamar blue in 4 h, promastigotes
were only weakly able to do so after long term incubation.
In agreement with previous report on the antileishmanial
effect of abietane diterpenes [24], the effect of diterpenes
1–4 was more pronounced in the amastigotes, mamma-
lian-stage of the parasite than the promastigote, insect-
stage. On the other hand, the antileishmanial effect of
AMB which is known to be mediated through formation
of membrane channels permeable to water and ions [30]
and references there in) was not developmental stage spe-
cific as both promastigotes and amastigotes were equally
susceptible to AMB. The order of potency of diterpenes 1–
3 was similar with their antibacterial effects in previous
studies [13,14]:i.e. 2 >1 >3.
It is interesting to note that differences between the toxic-
ity of the compounds studied to axenic amastigotes and
the permissive host cells, THP-1 cells were observed. In
previous studies, 50–500 µg/ml concentrations of
andrographolide (4) were reported as non-toxic to perito-
neal macrophages [22] but the study had limitations as
cells were exposed to the drug for only one hour. In the
present assay system, the same incubation time period (72
h) as the antileishmanial assay was used so that direct
comparison between toxicities to host cell and parasites
could be made. Andographolide (4) and the other lab-
dane diterpene (3) appear to be less selective as amastig-
otes/THP-1 toxicity ratio (see Table 1) was less than two.
On the other hand, the amastigotes/THP-1 toxicity ratio
for the clerodane diterpenes 1 and 2 were over 20 and 10
respectively. AMB did also show small but significant
toxicity at its higher concentrations. The most toxic side
effects that limit the clinical use of AMB, however, are
neurotoxicity and nephrotoxicity [31].
Conclusion
In summary, the present study demonstrate potent
antileishmanial activity of premna diterpenes (1–3). The
compounds were more potent in inhibiting the axeni-
cally-cultured amastigotes than promastigotes of L. aethi-
opica.  The clerodane diterpenes (1, 2) with more
selectivity to amastigotes than THP-1 cells are promising
and warrant further studies and/or development.
Methods
Chemicals and reagents
The isolation and characterisation of diterpenes (1–3)
have previously been described [13–15]. Andographolide
(4) and all tissue culture media and supplements were
obtained from Sigma-Aldrich Chemical Company (Dor-
set, UK). The stock solutions of test compounds were pre-
pared in dimethyl sulfoxide (DMSO) which was
subsequently diluted in the appropriate medium. All
DMSO concentrations used (less than 1%) did not show
any activity in cell viability studies (data not shown).
Cell culture
L. aethiopica (WHO designation: MHOM/ET/72/L100)
promastigotes as well as the human monocytic THP-1
cells were cultured with RPMI 1640 medium supple-
mented with 10% heat inactivated foetal bovine serum
(FBS), 2 mM L-glutamine, 50 IU/ml penicillin and 50 µg/
ml streptomycin. Cultures were maintained at their
Table 1: Antileishmanial activity of diterpenes (1–4) and AMB. LD50 values in µg/ml obtained from a minimum of three separate 
experiments are shown.
Drugs L. aethiopica THP-1
promastigotes amastigotes
AMB 0.189 ± 0.01 (n = 3) 0.183 ± 0.04 (n = 6) >10
1 > 100 4.12 ± 0.28 (n = 5) >100
2 11.67 ± 0.88 (n = 3) 1.08 ± 0.25 (n = 5) 12.13 ± 1.42 (n = 4)
3 > 100 19.2 ± 2.24 (n = 5) 26 ± 3.89 (n = 4)
4 18. 33 ± 1.05 (n = 3) 4.52 ± 0.97 (n = 5) 7 ± 1.08 (n = 4)BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/6
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optimum temperature, i.e. 22 and 37°C (5% CO2)
respectively.
Promastigotes and drug susceptibility assay
For drug susceptibility assays, 106 cells/ml promastigotes
were seeded in 96-well flat-bottom plates in final volume
of 200 µl. Various concentrations of experimental drugs
made in three-fold dilutions were then added to triplicate
wells and plates incubated for 72 h at 22°C. At the end of
incubation, cell viability was measured by counting the
number of motile cells using a haemocytometer. For each
drug, the concentration-response curve was plotted from
which LD50 values (the concentration of the agent that
reduce cell viability by 50% compared to controls) were
determined. All experiments were repeated at least three
times.
Axenically-cultured amastigotes and drug susceptibility 
assay
Late stationary phase (3 × 107 cells/ml) promastigotes
were centrifuged and re-suspended in medium 199 with
Hank's salts supplemented with 20% FBS, 2 mM L-
glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin
and the pH titrated to 5.5 using 1 N HCl. Following incu-
Figure 4
Morphological features of L. aethiopica promastig-
otes and axenically-cultured amastigotes. Mid-log 
stage promastigotes and amastigote forms were fixed with 
formaldehyde and viewed under Zeiss Axioskop phase con-
trast microscope. Photographs were immediately taken using 
Olympus-2 camera under oil immersion and 1000 × magnifi-
cation. Arrows indicate promastigotes undergoing cell 
division.
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Figure 5
Toxicity of diterpenes (1–4) (panel-A) and AMB 
(panel-B) in THP-1 monocytes. Cell viability was meas-
ured using almar blue as described in the methods section. 
Data points are mean and SEM values obtained from six rep-
licates. For symbols: see Fig. 3. In the AMB treatment group 
(panel-B), * and ** represent significant differences (unpaired 
t-test) compared to untreated control group at the level of p 
= 0.05 and p = 0.01 respectively.
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bation of cells at 31°C, 5% CO2, amastigote-like rounded
morphology together with loss of flagella and cell clump-
ing started appearing within 24 h but these changes were
not synchronous for a week as some motile parasites with
intermediate forms and short flagella were detected. Drug
treatment of the amastigotes was essentially similar with
the promastigotes culture described above. Briefly, amas-
tigotes (4 week old following initiation of differentiation)
were incubated for 72 h at 31°C, 5% CO2 in the presence
or absence of drugs. Alamar Blue™ (20 µl; Serotec, UK)
was added during the last 4 h of incubation and viability
measured fluorometrically by using Labsystem's
Fluoroskan Ascent flourimeter at excitation wavelength of
544 nm and emission at 590 nm.
Assessment of drugs toxicity in THP-1 monocytes
THP-1 monocytes were plated onto 96 well plates at a
density of 4 × 104 cells per well (in 200 µl volume) in the
presence or absence of experimental agents and plates
incubated at 37°C, 5% CO2 for 72 h. After adding Alamar
Blue™ during the last 3 h of incubation, cell viability was
measured fluorometrically as described above.
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